{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:45:43Z","timestamp":1794048343119,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760303"],"award-info":[{"award-number":["81760303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48171-5","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:46:54Z","timestamp":1776001614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the surface lipoprotein assembly modifier (Slam) as a vaccine candidate against Neisseria gonorrhoeae infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Ya","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"48171_CR1","doi-asserted-by":"publisher","unstructured":"Lin, E. Y., Adamson, P. C. &  Klausner, J. D.  Epidemiology treatments, and vaccine development for antimicrobial-resistant Neisseria gonorrhoeae: current strategies and future directions. Drugs 81, 1153\u20131169. https:\/\/doi.org\/10.1007\/s40265-021-01530-0 (2021).","DOI":"10.1007\/s40265-021-01530-0"},{"key":"48171_CR2","doi-asserted-by":"publisher","first-page":"e0009423","DOI":"10.1128\/cmr.00094-23","volume":"37","author":"E Williams","year":"2024","unstructured":"Williams, E. et al. Neisseria gonorrhoeae vaccines: a contemporary overview. Clin. Microbiol. Rev. 37, e0009423. https:\/\/doi.org\/10.1128\/cmr.00094-23 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"48171_CR3","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/aac.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi, M. et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55, 3538\u20133545. https:\/\/doi.org\/10.1128\/aac.00325-11 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48171_CR4","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1073\/pnas.0915162107","volume":"107","author":"D Serruto","year":"2010","unstructured":"Serruto, D. et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc. Natl. Acad. Sci. U S A. 107, 3770\u20133775. https:\/\/doi.org\/10.1073\/pnas.0915162107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"48171_CR5","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1074\/jbc.REV120.008745","volume":"296","author":"GB Cole","year":"2021","unstructured":"Cole, G. B., Bateman, T. J. & Moraes, T. F. The surface lipoproteins of gram-negative bacteria: protectors and foragers in harsh environments. J. Biol. Chem. 296, 100147. https:\/\/doi.org\/10.1074\/jbc.REV120.008745 (2021).","journal-title":"J. Biol. Chem."},{"key":"48171_CR6","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/nmicrobiol.2016.9","volume":"1","author":"Y Hooda","year":"2016","unstructured":"Hooda, Y. et al. Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria. Nat. Microbiol. 1, 16009. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.9 (2016).","journal-title":"Nat. Microbiol."},{"key":"48171_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fcimb.2017.00207","volume":"7","author":"Y Hooda","year":"2017","unstructured":"Hooda, Y., Lai, C. C. L. & Moraes, T. F. Identification of a large family of Slam-dependent surface lipoproteins in gram-negative bacteria. Front. Cell. Infect. Microbiol. 7, 207. https:\/\/doi.org\/10.3389\/fcimb.2017.00207 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"48171_CR8","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkab398","volume":"49","author":"S Yao","year":"2021","unstructured":"Yao, S. et al. NetGO 2.0: improving large-scale protein function prediction with massive sequence, text, domain, family and network information. Nucleic Acids Res. 49, W469\u2013w475. https:\/\/doi.org\/10.1093\/nar\/gkab398 (2021).","journal-title":"Nucleic Acids Res."},{"key":"48171_CR9","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gkae407","volume":"52","author":"Z Yan","year":"2024","unstructured":"Yan, Z. et al. Next-generation IEDB tools: a platform for epitope prediction and analysis. Nucleic Acids Res. 52, W526\u2013w532. https:\/\/doi.org\/10.1093\/nar\/gkae407 (2024).","journal-title":"Nucleic Acids Res."},{"key":"48171_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S. Y. The HDOCK server for integrated protein-protein docking. Nat. Protoc. 15, 1829\u20131852. https:\/\/doi.org\/10.1038\/s41596-020-0312-x (2020).","journal-title":"Nat. Protoc."},{"key":"48171_CR11","doi-asserted-by":"publisher","first-page":"1473193","DOI":"10.3389\/fimmu.2024.1473193","volume":"15","author":"Q Lu","year":"2024","unstructured":"Lu, Q. et al. Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae. Front. Immunol. 15, 1473193. https:\/\/doi.org\/10.3389\/fimmu.2024.1473193 (2024).","journal-title":"Front. Immunol."},{"key":"48171_CR12","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","volume":"9","author":"A Lovett","year":"2018","unstructured":"Lovett, A. & Duncan, J. A. Human immune responses and the natural history of Neisseria gonorrhoeae infection. Front. Immunol. 9, 3187. https:\/\/doi.org\/10.3389\/fimmu.2018.03187 (2018).","journal-title":"Front. Immunol."},{"key":"48171_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","volume":"16","author":"SJ Quillin","year":"2018","unstructured":"Quillin, S. J. & Seifert, H. S. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat. Rev. Microbiol. 16, 226\u2013240. https:\/\/doi.org\/10.1038\/nrmicro.2017.169 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"48171_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3389\/fimmu.2020.01375","volume":"11","author":"MW Russell","year":"2020","unstructured":"Russell, M. W., Gray-Owen, S. D. & Jerse, A. E. Editorial: Immunity to Neisseria gonorrhoeae. Front. Immunol. 11, 1375. https:\/\/doi.org\/10.3389\/fimmu.2020.01375 (2020).","journal-title":"Front. Immunol."},{"key":"48171_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.chom.2025.05.015","volume":"33","author":"EA Kurt-Jones","year":"2025","unstructured":"Kurt-Jones, E. A. et al. Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolism. Cell. Host Microbe. 33, 1133\u20131145e1134. https:\/\/doi.org\/10.1016\/j.chom.2025.05.015 (2025).","journal-title":"Cell. Host Microbe"},{"key":"48171_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40259-013-0034-5","volume":"27","author":"A Schubert-Unkmeir","year":"2013","unstructured":"Schubert-Unkmeir, A. & Christodoulides, M. Genome-based bacterial vaccines: current state and future outlook. BioDrugs 27, 419\u2013430. https:\/\/doi.org\/10.1007\/s40259-013-0034-5 (2013).","journal-title":"BioDrugs"},{"key":"48171_CR17","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"M Pizza","year":"2000","unstructured":"Pizza, M. et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816\u20131820. https:\/\/doi.org\/10.1126\/science.287.5459.1816 (2000).","journal-title":"Science"},{"key":"48171_CR18","doi-asserted-by":"publisher","unstructured":"Velimirov, B. & Velimirov, B. A. Immune responses elicited by outer membrane vesicles of gram-negative bacteria: important players in vaccine development. Life (Basel). 14, 256. https:\/\/doi.org\/10.3390\/life14121584 (2024).","DOI":"10.3390\/life14121584"},{"key":"48171_CR19","doi-asserted-by":"crossref","unstructured":"Calvaresi, V. et al. Structural dynamics and immunogenicity of the recombinant and outer membrane vesicle-embedded Meningococcal antigen NadA  (2024).","DOI":"10.1101\/2024.01.30.577382"},{"key":"48171_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41541-024-01018-4","volume":"9","author":"YL Tzeng","year":"2024","unstructured":"Tzeng, Y. L., Sannigrahi, S. & Stephens, D. S. NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae. NPJ Vaccines. 9, 223. https:\/\/doi.org\/10.1038\/s41541-024-01018-4 (2024).","journal-title":"NPJ Vaccines"},{"key":"48171_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/mi.2009.139","volume":"3","author":"B Feinen","year":"2010","unstructured":"Feinen, B., Jerse, A. E., Gaffen, S. L. & Russell, M. W. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 3, 312\u2013321. https:\/\/doi.org\/10.1038\/mi.2009.139 (2010).","journal-title":"Mucosal Immunol."},{"key":"48171_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills, K. H. G. IL-17 and IL-17-producing cells in protection versus pathology. Nat. Rev. Immunol. 23, 38\u201354. https:\/\/doi.org\/10.1038\/s41577-022-00746-9 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"48171_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mi.2012.12","volume":"5","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Islam, E. A., Jarvis, G. A., Gray-Owen, S. D. & Russell, M. W. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-\u03b2-dependent mechanisms. Mucosal Immunol. 5, 320\u2013331. https:\/\/doi.org\/10.1038\/mi.2012.12 (2012).","journal-title":"Mucosal Immunol."},{"key":"48171_CR24","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1093\/infdis\/jiae289","volume":"230","author":"Y Ruiz Garc\u00eda","year":"2024","unstructured":"Ruiz Garc\u00eda, Y. et al. Urgent need to understand and prevent gonococcal infection: from the laboratory to real-world context. J. Infect. Dis. 230, e758\u2013e767. https:\/\/doi.org\/10.1093\/infdis\/jiae289 (2024).","journal-title":"J. Infect. Dis."},{"key":"48171_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","volume":"39","author":"GK Pedersen","year":"2018","unstructured":"Pedersen, G. K., Andersen, P. & Christensen, D. Immunocorrelates of CAF family adjuvants. Semin. Immunol. 39, 4\u201313. https:\/\/doi.org\/10.1016\/j.smim.2018.10.003 (2018).","journal-title":"Semin. Immunol."},{"key":"48171_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4049\/jimmunol.2000420","volume":"205","author":"J Schick","year":"2020","unstructured":"Schick, J. et al. Cutting edge: TNF is essential for mycobacteria-induced MINCLE expression, macrophage activation, and Th17 adjuvanticity. J. Immunol. 205, 323\u2013328. https:\/\/doi.org\/10.4049\/jimmunol.2000420 (2020).","journal-title":"J. Immunol."},{"key":"48171_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s1473-3099(19)30279-8","volume":"19","author":"S Abraham","year":"2019","unstructured":"Abraham, S. et al. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 19, 1091\u20131100. https:\/\/doi.org\/10.1016\/s1473-3099(19)30279-8 (2019).","journal-title":"Lancet Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48171-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:17:56Z","timestamp":1780438676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48171-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48171"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48171-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Animal Ethics Committee of Dali University (Approval No. 2024-PZ-028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"16999"}}